Internal Medicine · Pittsburgh, PA
NPI
1356581201
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
320 E North Ave
Pittsburgh, PA, 15212
Phone (412) 359-3030
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
2,511 services
Medicare patients, 2024
458
Average age 73
Drug cost, 2024
$9.3M
58,802 prescriptions
Company payments, 2025
$2,205
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mikhail Chilingaryan was code 99214 (office e&m - established), 942 times for 396 patients. In total Mikhail Chilingaryan billed 2,511 services in 17 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 942 | 396 | $107.55 | $101K |
| 99457 E&M - Miscellaneous | Office | 444 | 59 | $41.94 | $19K |
| 99454 E&M - Miscellaneous | Office | 308 | 50 | $43.41 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 243 | 154 | $13.69 | $3,327 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 183 | 183 | $139.49 | $26K |
| 99350 Home E&M - New and Established | Office | 123 | 104 | $151.26 | $19K |
| 99213 Office E&M - Established | Office | 58 | 47 | $78.27 | $4,539 |
| 99204 Office E&M - New | Office | 25 | 25 | $136.29 | $3,407 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 14 | 14 | $46.58 | $652 |
By year: 2022 $289K for 5,446 services; 2023 $242K for 4,040 services; 2024 $193K for 2,511 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mikhail Chilingaryan prescribed most often to Medicare patients was Gabapentin, with 2,811 prescriptions and refills. In total Mikhail Chilingaryan wrote 58,802 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 2,811 | 2,872 | 328 | $17K |
| Rosuvastatin Calcium Generic | 2,151 | 2,363 | 267 | $9,928 |
| Hydralazine Hcl Generic | 1,491 | 1,528 | 184 | $9,404 |
| Donepezil Hcl Generic | 1,431 | 1,568 | 169 | $6,279 |
| Meclizine Hcl Generic | 1,339 | 1,416 | 173 | $7,957 |
| Omeprazole Generic | 1,323 | 1,413 | 161 | $3,011 |
| Amlodipine Besylate Generic | 1,313 | 1,448 | 159 | $2,511 |
| Atorvastatin Calcium Generic | 1,246 | 1,384 | 159 | $4,822 |
| Farxiga Dapagliflozin Propanediol | 980 | 1,022 | 144 | $584K |
| Metformin Hcl Generic | 972 | 1,063 | 125 | $72K |
| Clonidine Hcl Generic | 911 | 928 | 98 | $1,867 |
| Losartan Potassium Generic | 908 | 970 | 117 | $3,383 |
| Levothyroxine Sodium Generic | 898 | 1,018 | 103 | $3,806 |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 870 | 922 | 107 | $1.2M |
| Tamsulosin Hcl Generic | 827 | 869 | 92 | $3,391 |
Brand drugs: 10,102 claims; generic drugs: 47,732 claims; opioid claims: 556.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mikhail Chilingaryan $2,205 ($2,205 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $350.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $350 |
| Ardelyx, Inc. ARDX | 13 | $337 |
| Amgen Inc. AMGN | 8 | $229 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $226 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $148 |
| GlaxoSmithKline, LLC. GSK | 6 | $140 |
| Novo Nordisk Inc NVO | 5 | $132 |
| Axsome Therapeutics, Inc. AXSM | 5 | $120 |
| Lilly USA, LLC LLY | 4 | $92.96 |
| Aimmune Therapeutics, Inc. | 4 | $70.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.